Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BRBR | FLO |
|---|---|---|
| Price | $7.77 | $5.84 |
| Change today | ▲ 1.04% | ▲ 1.74% |
| Market cap | $903.48M | $1.24B |
| Return, 3 months | -36.0% | -26.2% |
| Return, year to date | -70.9% | -42.8% |
| Return, 1 year | -77.7% | -49.4% |
| P/E (TTM) | 5.5 | 22.5 |
| P/B | -1.9 | 0.9 |
| P/E percentile vs own 5y | 1st | 38th |
| Dividend yield | – | 14.86% |
| Revenue growth (YoY, latest qtr) | +4.2% | -4.0% |
| Net profit growth (YoY) | +62.9% | -30.3% |
| Gross margin | 28.6% | 48.6% |
| Operating margin | 13.3% | 5.5% |
| Net margin | 7.3% | 1.1% |
| Return on equity | – | 4.0% |
| Analyst target vs. price | +96.3% | -5.8% |
| Analyst buy share | 62% | 0% |
| RSI (14) | 32 | 42 |
| 30-day volatility | 49.4% | 27.2% |
| Max drawdown, 1 year | -79.9% | -54.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
